Katia Befort Selected Research

Anxiety Disorders (Anxiety Disorder)

2/2015

A novel anxiogenic role for the delta opioid receptor expressed in GABAergic forebrain neurons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katia Befort Research Topics

Disease

6	Pain (Aches) 01/2017 - 01/2002
5	Substance-Related Disorders (Drug Abuse) 01/2018 - 06/2004
4	Chronic Pain 01/2018 - 10/2011
3	Hypersensitivity (Allergy) 09/2005 - 01/2002
2	Obesity 04/2024 - 12/2021
2	Bulimia (Binge Eating) 01/2021 - 01/2020
1	Binge-Eating Disorder (Binge Eating Disorder) 05/2023
1	Body Weight (Weight, Body) 12/2021
1	Hyperphagia (Overeating) 12/2021
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2021
1	Neuroinflammatory Diseases 01/2020
1	Catalepsy 01/2017
1	Anxiety Disorders (Anxiety Disorder) 02/2015
1	Seizures (Absence Seizure) 02/2015
1	Mood Disorders (Mood Disorder) 02/2015
1	Heroin Dependence (Heroin Abuse) 10/2014
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 10/2011
1	Brain Diseases (Brain Disorder) 10/2011
1	Mental Disorders (Mental Disorder) 04/2011
1	Neuralgia (Stump Neuralgia) 09/2005
1	Hyperalgesia 09/2004
1	Peripheral Nerve Injuries 10/2002
1	Inflammation (Inflammations) 01/2002

Drug/Important Bio-Agent (IBA)

5	Opioid Analgesics (Opioids)IBA 01/2018 - 09/2005
4	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2020 - 06/2004
3	delta Opioid Receptors (delta Opioid Receptor)IBA 02/2015 - 10/2011
2	SugarsIBA 04/2024 - 12/2021
2	EndocannabinoidsIBA 05/2023 - 12/2021
2	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 04/2011
2	Cocaine (Cocaine HCl)IBA 11/2021 - 01/2020
2	Heroin (Diamorphine)IBA 01/2017 - 10/2014
2	Serotonin (5 Hydroxytryptamine)IBA 10/2014 - 04/2011
2	Opioid Receptors (Opioid Receptor)IBA 10/2014 - 01/2014
1	FatsIBA 04/2024
1	Messenger RNA (mRNA)IBA 12/2021
1	CB2 Cannabinoid ReceptorIBA 12/2021
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2021
1	Sucrose (Saccharose)IBA 01/2021
1	SolutionsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2015
1	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 02/2015
1	ConvulsantsIBA 02/2015
1	Peptides (Polypeptides)IBA 01/2014
1	CannabinoidsIBA 04/2011
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2011
1	Glutamic Acid (Glutamate)FDA Link 04/2011
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 09/2005
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2004
1	Capsaicin (Zostrix)FDA Link 09/2004
1	D-Penicillamine (2,5)- EnkephalinIBA 04/2004
1	Ala(2)- deltorphin IIIBA 04/2004
1	OligonucleotidesIBA 10/2002
1	preproenkephalinIBA 01/2002
1	Freund's AdjuvantIBA 01/2002
1	U 0126 (UO 126)IBA 01/2002
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2002
1	Mitogen-Activated Protein KinasesIBA 01/2002

Therapy/Procedure

1	Injections 01/2018
1	Ligation 09/2005
1	Axotomy 09/2005
1	Spinal Injections 01/2002